US suspends chikungunya vaccine Ixchiq over ‘serious’ side effects: Valneva

US health authorities have suspended the licence for the Ixchiq vaccine against the chikungunya virus following reports of “serious adverse events”, the drug’s French maker said on Monday (Aug 25). Ixchiq is one of just two vaccines approved by the US Food and Drug Administration for the mosquito-spread virus, which mainly occurs in tropical and…

Read More

You cannot copy content of this page